Narayana Hrudayalaya Limited Board Approves Unaudited Financial Results for Q3 FY2026

Narayana Hrudayalaya Limited announced the approval of its Unaudited Standalone and Consolidated Financial Results for the quarter and nine months ended December 31, 2025, following the Board meeting on February 13, 2026. Standalone Net Profit for Q3 stood at ₹757.37 million. The consolidated results included an exceptional item of ₹509.36 million related to the impact of new Labour Codes. The results also detail several ongoing corporate reorganization schemes.

Unaudited Results Declaration for Q3 FY2026

The Board of Directors of Narayana Hrudayalaya Limited convened on February 13, 2026, to approve the Unaudited Standalone and Consolidated Financial Results for the quarter and nine months ended December 31, 2025. This approval was granted pursuant to applicable regulatory requirements.

Standalone Financial Highlights (Q3 Ended Dec 31, 2025)

Key figures from the standalone statement for the quarter ended December 31, 2025 (Unaudited) include:

  • Total Income: ₹9,846.32 million (compared to ₹10,362.57 million in the previous quarter).
  • EBITDA: ₹2,206.15 million.
  • Profit Before Tax (after exceptional items): ₹992.62 million.
  • Net Profit for the period: ₹757.37 million.
  • Diluted Earnings Per Share: ₹3.90.

For the nine months ended December 31, 2025, the standalone Net Profit was ₹3,009.88 million, with Diluted EPS at ₹14.82.

Consolidated Financial Overview (Q3 Ended Dec 31, 2025)

The consolidated results reflect the performance of the Group, including subsidiaries, associates, and joint ventures. The review was based partially on the unreviewed interim data of certain entities.

A significant feature in the consolidated results was the recognition of an Exceptional Item amounting to ₹509.36 million in the quarter and nine months ended December 31, 2025. This charge relates to the estimated incremental gratuity and leave liability resulting from new Indian Labour Codes notified in November 2025.

Discontinued Operations Impact

The results also incorporate the impact of discontinued operations related to Narayana Vaishno Devi Speciality Hospitals Private Limited (NVD), which is subject to a management agreement transfer.

  • The loss from discontinued operations after taxes for the quarter was (₹13.01 million).
  • Total Comprehensive Income/(Loss) for the quarter was (₹13.44 million).

Corporate Developments Noted

Several corporate restructuring activities were noted, which impact the comparability of prior periods:

  • The merger scheme involving Meridian Medical Research & Hospital Ltd. (MMRHL) was progressing, with necessary tribunal filings completed by January 23, 2026.
  • A Scheme of Arrangement was approved to demerge clinical services from NH Integrated Care Private Limited (NHIC) into the Resulting Company, effective April 1, 2025.
  • A wholly owned subsidiary, Narayana Healthcare North Private Limited (NHNPL), was incorporated on January 16, 2026.
  • The acquisition of 100% equity in Practice Plus Group Hospitals Limited (PPG UK) by Narayana Hrudayalaya UK Ltd. was completed on November 6, 2025.

Source: BSE

Previous Article

Entero Healthcare Solutions Limited Submission of Unaudited Financial Results for Q3 FY2025-26

Next Article

AWL Agri Business Limited Achieves Score of 60 in Latest S&P Global Corporate Sustainability Assessment